A urinary biosignature for mitochondrial myopathy, encephalopathy, lactic acidosis and stroke like episodes (MELAS)
Karien Esterhuizen(North-West University), Roan Louw(North-West University), Shayne Mason(North-West University), Jan Smeıtınk(Khondrion (Netherlands)), Jeremie Zander Lindeque(North-West University), Anna H. Hakonen(University of Helsinki), Francois H. van der Westhuizen(North-West University), Mirian C. H. Janssen(Radboud University Nijmegen), Anu Suomalainen(University of Helsinki), Paul de Laat(Radboud University Nijmegen), Richard J. Rodenburg(Radboud University Nijmegen), Christopher J. Carroll(St George's, University of London)
Cited by 25
Related Papers
Mitochondrial diseases
|Nature Reviews Disease Primers|2016|1.5k
FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study
|The Lancet Neurology|2011|420
Leigh Syndrome with Nephropathy and CoQ10 Deficiency Due to decaprenyl diphosphate synthase subunit 2 (PDSS2) Mutations
|The American Journal of Human Genetics|2006|393
Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
|EMBO Molecular Medicine|2014|386